Paraventricular nucleus-pineal interaction: relevance to tardive dyskinesia.
R
R
Sandyk
S R
SR
Kay
D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D001921:Brain / Q000503:physiopathology; D001927:Brain Diseases / Q000139:chemically induced* / Q000150:complications / Q000503:physiopathology; D004409:Dyskinesia, Drug-Induced / Q000209:etiology* / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D008550:Melatonin / Q000378:metabolism; D001523:Mental Disorders / Q000188:drug therapy* / Q000503:physiopathology; D010286:Paraventricular Hypothalamic Nucleus / Q000187:drug effects* / Q000503:physiopathology; D012307:Risk Factors; D014667:Vasopressins / Q000378:metabolism
D014150:Antipsychotic Agents; D014667:Vasopressins; D008550:Melatonin